Description
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Purity | ≥98% |
|---|---|
| Formula | C25H39H7O8 |
| Formula Wt. | 565.63 |
| Synonym | EHIPA. |
| Solubility | Soluble in water (2 mg/mL). |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Gartner TK, Loudon R, Taylor DB. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1446-52. PMID: 1953789.
ATR inhibitor.
V600E B-Raf inhibitor.
B-Raf and c-Raf inhibitor.
Non-endogenous essential vitamin (B9), found in...
USP1 inhibitor
Endogenous peptide hormone fragment, involved i...
Peptide, derivative of AT I, cleavage product o...
NSAID; COX-2 inhibitor.
Sulforaphane-cysteine conjugate.
Recombinant HCV antigen fragment.
Synthetic glutathione peroxidase mimetic; yeast...
Wnt/β-catenin inhibitor
CDK2 inhibitor
Tricyclic benzonaphthyridinone; mTORC1/2 inhibi...
Vitamin A derivative; RAR and RXR agonist.
Steroidal saponin found in Tribulus, Trigonella...
Mycotoxin produced by species of Aspergillus; D...
Anti-diabetic alkaloid
Nicotinamide analog prodrug; fatty acid synthet...
Ethisterone derivative, synthetic steroid, used...